ABSTRACT: Introduction: Contemporaneous measures of muscle architecture and force have not previously been conducted during critical illness to examine their relationship with intensive care unit (ICU)-acquired weakness. Methods: Ankle dorsiflexor muscle force (ADMF) with high-frequency electrical peroneal nerve stimulation and skeletal muscle architecture via ultrasound were measured in 21 adult, critically ill patients, 16 at ICU admission. Results: Thirteen patients were measured on 2 occasions. Among these, 10 who were measured at ICU admission demonstrated muscle weakness. Despite significant reductions in tibialis anterior (D 5 288.5 6 78.8 mm 2 , P 5 0.002) and rectus femoris (D 5 2126.1 6 129.1 mm 2 , P 5 0.006) cross-sectional areas between occasions, ADMF did not change (100-HZ ankle dorsiflexor force 9.8 [IQR,] kg vs. 8.6 (IQR, 6.7-19.2) kg, P 5 0.9). Discussion: Muscle weakness was evident at ICU admission. No additional decrements were observed 7 days later despite significant reductions in muscle size. These data suggest that not all ICU weakness is truly "acquired" and questions our understanding of muscle function during critical illness. 57: 964-972, 2018 
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Peripheral skeletal muscle wasting is an acute insult of critical illness 1 and may contribute to the development of intensive care unit-acquired weakness (ICU-AW). Recent data from a longitudinal prospective cohort study of survivors of acute respiratory distress syndrome demonstrated that patients with ongoing ICU-AW at hospital discharge had worse 5 year survival than those without weakness. 2 Ultrasound has increasingly been used to assess muscle function by measuring parameters of muscle architecture such as crosssectional area (CSA) and echogenicity. 3 Sequential measurements of CSA have previously demonstrated a reduction of almost 20% in muscle bulk in critically ill patients during the first 10 days of ICU admission. 1 Furthermore, in a comparison of ultrasound-derived echogenicity data (a machinegenerated parameter 4 ) to histological specimens, echogenicity was reported to have a predictive capacity for development of myofiber necrosis, 5 a clinically relevant finding.
Such measurements of peripheral skeletal muscle architecture do not, however, provide information on contractile properties and force-generating capacity of muscle. Volitional manual muscle testing is restricted to patients sufficiently conscious to perform testing and cannot distinguish true loss of muscle strength from poor motivation and impaired cognition. 6, 7 In contrast, nonvolitional techniques involving electrical or magnetic motor nerve stimulation eliminate the limitations imposed by patient cooperation, patient motivation, and the clinical environment. Nonvolitional measurements of muscle contractility in critically ill patients have been reported for adductor pollicis, [8] [9] [10] tibialis anterior (TA), 11, 12 and quadriceps 13 muscle groups, albeit acquired by using either the single twitch response or trains of up to 4 stimuli and, therefore, not reflecting true muscle strength. 100-HZ electrical stimulation of the peroneal nerve is tolerable in healthy individuals and in patients with chronic obstructive pulmonary disease (COPD) 14, 15 and, unlike other nonvolitional techniques, [8] [9] [10] [11] [12] [13] the evoked tetanic contraction force reflects true muscle strength, being equal to that obtained during a maximal voluntary contraction. 15, 16 In addition, assessment of ankle dorsiflexor muscle force (ADMF) is minimally disruptive to patient position or treatment and therefore relatively easy to apply in the ICU environment.
This study sought to measure the degree and trajectory of change in peripheral skeletal muscle strength in patients admitted to ICU by measuring ADMF and its relationship with contemporaneous assessment of peripheral skeletal muscle (TA) architecture.
MATERIALS AND METHODS
Ethics Approval. Ethical approval was granted by the National Research Ethics Committee London-Camden & Islington (13/LO/02630), and the study conformed to the standards set by the Declaration of Helsinki (1996) . Written informed consent for participation was obtained from all participants' nominated next of kin or medical consultant.
Study Design and Setting. The study was undertaken in 3 tertiary referral ICUs (liver, medical, surgical) of a university teaching hospital. Measurements were performed in patients on 2 occasions separated by 7 days.
Participants. Adult (18 years) patients admitted to ICU and likely to require invasive mechanical ventilation for at least 48 h and remain in the ICU for 7 days were eligible for inclusion. Patients could be recruited at any point during ICU admission. Exclusion criteria included acute neurological diagnoses, chronic neuropathies or myopathies, receipt of neuromuscular blocking agents, trauma injuries (precluding lower limb strength assessment), and pregnancy. The right leg was assessed unless this was impaired by clinical factors at the time of initial testing. The same leg was used for reassessment. All patients received standard physical therapy during ICU admission at the autonomous discretion of their treating therapist. Typically, this involved functional mobilization activities; electrical muscle stimulation and in-bed cycle ergometry were not employed.
Ankle Dorsiflexor Muscle Force. The equipment has been described previously 14, 15 (for full details, see Supp. Info. E1). Briefly, ADMF was measured by using a bespoke testing device into which the distal lower leg was secured. ADMF elicited by supramaximal electrical stimulation of the common peroneal nerve was measured by using a strain gauge attached to the underside of the device footplate. Force response to single twitch (TwAD) and 1-s trains of electrical stimulation at 5, 10, 20, 30, 40, 50, 80, and 100 HZ (100-HZAD) were recorded. Stimulation at half-maximal tetanic tension and the maximal relaxation rate (MRR) of the twitch response were determined. Mean 6 SD betweenoccasion coefficients of variation for TwAD and 100-HZAD were 6.5% 6 1.7% and 3.5% 6 0.7% respectively.
Ultrasound Imaging of Peripheral Skeletal Muscle. TA and quadriceps rectus femoris (RF) muscle CSA, pennation angle, echogenicity, and subcutaneous thickness were assessed by an experienced investigator (BC) by using realtime B-mode ultrasound. 1, 14, 15 Ultrasound imaging techniques are summarized below, with full details in Supporting Information E2.
Tibialis Anterior. Images of TA CSA (TA CSA ), TA pennation angle, TA echogenicity, and TA subcutaneous thickness were acquired by using 2-6-MHZ curvilinear and 4-12-MHZ linear (pennation angle only) transducers (C6-2 and L12-4 respectively; Philips Sparq Ultrasound System; Philips Healthcare, Andover, MA) from the superior aspect of the distal lower limb at a point one-third of the distance from the tibial plateau to the lateral malleolus, with the participant semisupine, the knee supported in passive extension, and the foot supported in neutral. [17] [18] [19] Oblique crosssectional imaging was minimized by the operator by using visual inspection to obtain the smallest CSA. Scanning depth of TA was set such that the deep margin of the muscle could be visualized between the tibia and the fibula.
Quadriceps RF. Imaging of RF muscle architecture (RF CSA , RF echogenicity, RF pennation [RF PA ], RF subcutaneous thickness) was performed in a similar manner (Supp. Info. E2), with the quadriceps muscle measured at a point two-thirds of the distance from the anterior superior iliac spine and the superior patellar border. Visualization of the femur was used to assist scanning depth. RF PA was imaged with the probe rotated 908, and the average value from 5 individual fiber angles was determined.
Statistical Analysis. Data were tested for normality and are expressed as either mean 6 SD or median (interquartile range (IQR)). Differences in ADMF and architecture parameters between testing occasions were determined with Wilcoxon signed-rank tests. Predicted values and cutoffs for 100-HZAD were determined from a regression model derived in similarly aged healthy controls 14 : 100-HZAD (kg) 5 4.431 1 20.116age 1 0.030TA CSA 2 0.389 if female. Muscle weakness in critically ill patients was defined as 1.645 residual SD below the predicted value derived from 100-HZAD responses from healthy individuals. Thresholds of losses in CSA exceeding 9.24% 20 and 3.48% 18 were used to define muscle wasting in RF and TA muscles, respectively. Relationships between ADMF and TA muscle architecture were assessed by using Spearman's correlation analysis. P < 0.05 was considered statistically significant. Data were analyzed in SPSS (SPSS Inc, Chicago, IL) and Prism (v6 for Windows; GraphPad Software, La Jolla, CA).
RESULTS
Participants. Twenty-five patients were recruited between June 2013 and July 2014. Three patients were unable to undergo testing because of clinical deterioration between recruitment and testing (1 death, 1 posttracheostomy procedure, 1 postextubation). One additional patient was unable to complete assessment because of withdrawal of personal consultee advice. Among the remaining 21 patients enrolled, 16 underwent initial testing within 24 h of ICU admission. Characteristics of the cohort are presented in Table 1 . By the second testing occasion, 3 patients had died, 1 patient refused consent for ongoing participation, and, in 4 patients, deterioration in clinical status precluded testing. Overall, 13 patients were reassessed on the second occasion (10 [76.9%] with initial testing at ICU admission). All patients were intubated on the first testing occasion. Five of the 13 patients tested on the second occasion had been extubated but remained in the critical care unit.
Ankle Dorsiflexor Muscle Force. No adverse events occurred during testing, and measurement of ADMF was feasible and well tolerated by all patients. In the overall cohort of 21 patients, TwAD and 100-HZAD were 3.0 (IQR 2.2-4.2) kg and 10.5 (IQR, 8.8-15.2) kg, respectively. There was no difference in TwAD or 100-HZAD between patients recruited at or during ICU admission (Table 2 ). In the 13 patients with repeat measurements, there were no changes in TwAD, 100-HZAD, or TwAD and 100-HZAD normalized to TA CSA , between testing occasions (Table 3 , Fig. 1 ). Complete force-frequency curves were obtained in all patients at initial testing and in 12 of 13 patients on the second testing occasion, when 1 patient was measured at 100 HZ only (Fig. 2) . Summary values for the whole cohort at initial and second testing occasions are shown in Figure 3 . There was no difference in stimulation frequency for half-maximal tetanic contraction or MRR on the first testing occasion compared with the second.
TA and Quadriceps RF Muscle Architecture. No differences in muscle architecture for TA and RF were observed between patients recruited at or during ICU admission (Table 2 ). Among patients with repeat assessments (Table 3) , it was not possible to measure RF muscle architecture in 1 patient on either day because of obesity, and RF PA could not be accurately measured in 4 patients. Significant reductions were observed in both TA CSA between testing occasions, Between testing occasions, n 5 13
Inotropes, n; d, mean 6 SD 11; 4.4 6 2. equivalent to overall percentage reductions of 29.6% 6 9.5% and 217.2% 6 15.5%, respectively. Individual trajectories of change for both muscle groups are presented in Supporting Information E3.
Wasting, as defined above, was observed in 10 of 12 (83.3%) patients for RF and 10 of 13 (76.9%) patients for TA muscles between testing occasions. Wasting of both muscle groups was Predicted Weakness. By using the previously described regression model, predicted values for 100-HZAD were determined in 19 of the 21 patients of the main cohort (2 were missing TA CSA data); observed 100-HZAD was found to be significantly lower than predicted 100-HZAD (Table 2) , and weakness was evident in 16 (84.2%) patients. A similar pattern was evident when examining the 16 patients from the main cohort who were tested within 24 h of ICU admission. Fourteen patients (same 2 missing data) had significantly reduced 100-HZAD compared with predicted 100-HZAD (Table 2) , with 12 patients demonstrating weakness.
Predicted 100-HZAD values were also determined for the 13 patients assessed on both occasions. ADMF weakness was observed in 12 patients on testing occasion 1 and in 11 patients on occasion 2. On both occasions, 100-HZAD was significantly lower than predicted.
DISCUSSION
In this study involving contemporaneous measures of muscle strength and architecture, significant ankle dorsiflexor muscle weakness was observed in critically ill patients on admission to ICU. Despite significant reductions in TA CSA FIGURE 1. Change in ankle dorsiflexor force (100-HZAD) between testing occasions (n 5 13 patients assessed on each occasion). during the critical illness course, no further decrements in ADMF were observed. Although changes in CSA were observed in both proximal (RF) and distal (TA) lower limb muscles, only RF showed changes in muscle quality.
Our data suggest antecedent decline in forcegenerating capacity prior to ICU admission. The reduced strength on ICU admission could therefore reflect a combination of the development of critical illness as well as the presence of chronic comorbidity. This, in combination with absence of further decline in muscle force during the admission period, challenges the commonly accepted term ICU-acquired weakness. Certainly this presentation is a clinical diagnosis of exclusion following treatment of all identifiable causes, including the ICU-admission diagnosis. 21 Nonetheless, weakness developing pre-ICU admission is also a feature.
Critical illness-associated weakness may be a more reflective term; further investigation in larger cohorts of patients with varying degrees of preexisting weakness would be valuable. These data also suggest that other mechanisms, such as changes within the central nervous system resulting in impaired muscle recruitment and reduced volitional muscle strength, could be important in explaining the profound impairment observed in many survivors of critical illness. 22, 23 We have confirmed previous findings of reduced muscle contractility in sedated and ventilated critically ill patients. [8] [9] [10] [11] [12] [13] Longitudinal as well as cross-sectional measurements were performed in the current study, and most initial testing was undertaken on day 1 of ICU admission. Such measures allowed not only characterization of the underlying level of muscle weakness at ICU admission but also the ongoing impact of ICU stay. Our data demonstrate that the initial insult of critical illness on muscle force occurs early, possibly prior to hospitalization, and does not continue to the same degree during the illness course. We cannot, however, exclude changes in muscle function that occurred immediately on entry to ICU prior to assessment of skeletal muscle function. We also observed no consistent relationship between peripheral skeletal muscle size and force at either time of assessment. This could be a result of a small sample resulting in type II error, but it also could be indicative of a limitation of the ultrasound technique.
Previous studies from this laboratory and others have demonstrated relationships between muscle size and strength in the knee extensor 24, 25 and ankle dorsiflexor muscles 14, 15 of COPD patients and age-matched controls. Nonetheless, muscle CSA does not fully account for variation in muscle strength. Although the current ultrasound findings mirror previously reported declines in such parameters in ICU patients, 3 ultrasonographic evaluation of muscle architecture reflects solely morphological features. Therefore, the effects on muscle CSA of changes in lean muscle mass that are thought to occur during ICU admission could be masked by intrinsic alterations in muscle properties including infiltration of fat, fibrous tissue, or extracellular fluid. 4, 26, 27 It is possible that clinical procedures (sedation, neuromuscular blockade), immobilization, and altered fluid balance during the acute phase of critical illness lead to an overestimation of CSA on day 1 and would also explain the significant reductions in muscle CSA that were observed between day 1 of admission and day 7, despite no change in muscle strength. Furthermore this could also explain why a significant relationship between ADMF and TA CSA was observed only at the second assessment, later in the ICU stay. Despite significant reductions in RF CSA and TA CSA , there were no reductions in 100-HZAD. Differential atrophy of lower limb muscles has been demonstrated during prolonged bed rest, 28 and the predominant slow twitch fiber profile of the TA compared to the RF 29 may result in different responses in muscle architecture to the critical illness process. Such changes do not, however, explain the absence of change in muscle strength despite reductions in TA CSA . No changes were observed in TA echogenicity, half maximal tetanic tension, or MRR between testing occasions, which may have been expected if substantial changes in muscle quality 4 or muscle fiber composition had occurred. [30] [31] [32] It is also noteworthy that, although TwAD was similar to that reported previously by our group for healthy elderly adults of a comparable age, 14 TwAD: 100-HZAD was also increased. Such data highlight the limitations of the 1-HZ twitch technique. [33] [34] [35] Our cohort was a highly selected, nonsequential convenience sample determined by consultee assent and investigator availability. Although this limits generalizability, the cohort sizes were larger than any previous studies that examined sequential changes in neuromuscular ultrasound properties in critically ill patients 36, 37 or that involved nonvolitional assessment of skeletal muscle strength. 12, 13, 38 Nonetheless, we acknowledge that the small sample may yield unexpected findings and that only approximately two-thirds of the cohort underwent repeat testing. Half of the attrition, however, resulted from unmodifiable reasons of patient death or lack of consent. These occurrences, in combination with deteriorating clinical status in some patients, serve to highlight the overall challenges associated with studying this particular patient group. It is important to note that more than threequarters of patients in the overall cohort, and those who underwent testing on both occasions, were recruited within 24 h of ICU admission.
Animal studies have previously shown decrements in force generating capacity following prolonged immobilization. [39] [40] [41] Translating such findings to interpret our data is not straightforward. Unlike studies examining disuse atrophy in models employing healthy animals, the ICU patients studied were not fit and healthy prior to ICU admission, and all had multiple comorbidities. The weakness observed at ICU admission most likely reflects patients' previous physical condition as well as any acute insult of critical illness requiring ICU admission. Quadriceps contractility has been shown to be 4 times lower in ICU patients with preexisting sickness compared with healthy individuals but only 2 times lower than COPD patients. 13 The subsequent lack of change in skeletal muscle strength may also reflect opposing effects of immobilization, resolution of critical illness, the influence of physical activity via voluntary or involuntary movements, or focused physical rehabilitation. The lack of change in 100-HZAD may also have resulted from a "floor effect" and the inability of patients to weaken further (i.e., given the already reduced baseline muscle strength, further weakness was not possible). This was, however, a relatively small physiological study in a heterogenous ICU population. Larger studies are therefore highly recommended to validate these findings and examine the magnitude and trajectory of change in muscle strength across differing phenotypes of critically ill patients. Nonetheless, these data still question our knowledge regarding how muscle behaves in the context of critical illness across the spectrum of patients admitted to the ICU and whether all patients truly acquire weakness in the ICU.
Although the current study used the trace method to assess muscle echogenicity, Cartwright et al. 36 defined their region of interest (ROI) as a 2 3 2-cm portion within the muscle, and Grimm et al. 42 adopted the Heckmatt grading scale. The trace method was adopted because it offered a standardized approach that reflects changes across the entirety of muscles evaluated, regardless of size, and avoids sampling from adjacent muscle groups 43 and the influence of ROIs located in different portions of the muscle CSA image. 44 In the current study, the same experienced investigator (BC) performed all ultrasound measurements. Additional data are, however, required to determine the clinical relevance of echogenicity findings, for example, indicating myofiber necrosis 5 as well as the significance of measures of CSA obtained early in critical illness.
We assessed changes in muscle composition using echointensity analysis 4 alongside measurement of CSA because reductions in lean muscle mass could be masked by infiltration of fat, fibrous tissue, or extracellular fluid. 4, 26, 27 Echointensity findings for TA and RF muscles differed from previously reported studies in critical care patients in which changes analogous to mild muscle breakdown and disruption of normal muscle architecture akin to myopathy were noted, 36, 42 although these findings required muscle biopsy data for substantiation.
We applied muscle-specific thresholds for determining wasting of both TA 18 and RF 20 muscles, although only the latter were derived from a critically ill population. Nonetheless, this approach reflects a more accurate method for classification, avoiding assumptions that peripheral skeletal muscle groups with differing location (either proximal or distal), fiber type composition, and function demonstrate similar rates of wasting. Determining which peripheral muscle group best reflects patient status overall is unclear. Fiber type composition is not uniform across all muscle groups, and this limits the assumption of extrapolating weakness in 1 muscle to be representative of a generalized peripheral skeletal muscle weakness effect. Assessment of quadriceps function might be considered more "functionally" relevant 13 than TA; however, the patient repositioning required to measure quadriceps twitch tension is not unsubstantial in contrast to that required to assess ADMF, which requires minimal patient disturbance. Volitional scores of global muscle strength, such as the Medical Research Council Sum-score used to diagnose ICU-AW, 21 also omit key muscle groups important for upper limb function and dexterity such as the hand muscles. 45 We defined weakness using a regression equation incorporating values of TA CSA , age, and sex, 14 determined in age-matched healthy individuals. The relationship between muscle CSA measured by using ultrasound and strength has not been extensively investigated in critically ill patients. However we recognize that, under such circumstances, the disease pathology, severity of acute illness, and influence of various medical interventions may result in the relationships between muscle size and strength observed in healthy individuals no longer being entirely valid in this patient population. We also reported data for healthy individuals to demonstrate acceptable levels of interoccasion coefficients of variation and to infer confidence in the ADMF technique. Acquiring such reliability data (intraobserver, interobserver, or interoccasion) may not be feasible in the critically ill patient population, in which changes in clinical status would influence the results. This, in turn, highlights that variance evident in 100-HZAD in the current study must be related to the nature of the clinical condition of patients.
In conclusion, reduced force-generating capacity was evident in critically ill patients even on day 1 of ICU admission. No further decrements in ADMF were observed after 1 week despite the presence of significant reductions in TA CSA . These data contribute to our understanding of the individual trajectories of change in peripheral skeletal muscle during critical illness and the potential mechanism underlying such changes. Although use of ultrasound offers a clinically useful tool for monitoring parameters of muscle architecture, these data fail to provide a true physiological assessment of the functional status of the muscle.
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